Dementia in the News

Agencia EFE Salud (September 26, 2012): El alzhéimer es la epidemia silente del siglo XXI

Publication Date: 
Wed, 09/26/2012

Teresa Gómez Isla estuvo este verano dando un curso magistral sobre la enfermedad de Alzheimer en la Universidad Internacional Menéndez Pelayo, en Santander.

Ahora, desde Boston, esta investigadora, quien ha tratado al expresidente de la Generalitat catalana Pasqual Maragall, que sufre alzhéimer desde 2007,  habla con EFEsalud para analizar esta grave enfermedad.

National Institutes of Health (September 17, 2012): New Brain Cleaning System Discovered

Publication Date: 
Mon, 09/17/2012

Scientists have discovered a system that drains waste products from the brain. The finding may reveal ways to treat neurodegenerative disorders like Alzheimer's disease.

New York Times (September 11, 2012): A Longer Life is Lived in Company

Publication Date: 
Tue, 09/11/2012

YOU die alone, philosophers say. But you could die sooner if you live your life in loneliness. Close connections to friends and family may ward off poor health and premature death, recent research suggests.

AlzForum (September 6, 2012): Europe Asks if Reforming Health Habits Can Prevent Dementia

Publication Date: 
Thu, 09/06/2012

With an Alzheimer's epidemic looming, scientists, health officials, policymakers and the public are asking if anything can slow down this disease. Some prevention trials in the U.S. will test drug interventions but what about lifestyle modifications, such as eating better or exercising more? Some data suggest that tweaks in our routine could help, but in 2010 a panel from the National Institutes of Health deemed that evidence insufficient to justify formal recommendations.

Reuters (September 5, 2012): Alzheimer's Death Rate Higher in Former NFL Players

Publication Date: 
Wed, 09/05/2012

Retired pro football players seem to have higher-than-average risks of dying from Alzheimer's or Lou Gehrig's disease, U.S. governement researchers reported Wednesday.

In a study of more then 3,400 retired National Football League (NFL) players, the researchers found that death rates from the two brain diseases were four times higher than those in the general U.S. population. The researchers, from the National Institute for Occupational Safety and Health (NIOSH), cannot be sure of the reasons.

Harvard Medical School (August 23, 2012): For Mitochondria, Bigger May Not Be Better

Publication Date: 
Thu, 08/23/2012

Goldilocks was on to something when she preferred everything "just right." Harvard Medical School researchers have found that when it comes to the length of mitochondria, the power-producing organelles, applying the fairy tale's mantra is crucial to the health of a cell. More specifically, abnormalities in mitochondrail length promote the development of neurodegenerative diseases such as Alzheimer's.

USA Today (August 22, 2012): Men's Role in Helping Women with Alzheimer's, Dementia Soars

Publication Date: 
Wed, 08/22/2012

John Becklenberg says his wife, Mary Ann, still cooks their dinner, although her favorite recipes are simplified to one or two steps. She also hasn't relinquished tidying up the kitchen of their Dyed, Ind., home, but there's more clattering of pots and pans than ever before.

MIT News (August 20, 2012): Stroke Disrupts How Brain Controls Muscle Synergies

Publication Date: 
Mon, 08/20/2012

The simple act of picking up a pencil requires the coordination of dozens of muscles:  The eyes and head must turn toward the object as the hand reaches forward and the fingers grasp it. To make this job more manageable, the brain's motor cortex has implemented a system of shortcuts. Instead of controlling each muscle independently, the cortex is believed to activate muscles in groups, known as "muscle synergies." These synergies can be combined in different ways to achieve a wide range of movements.

AlzForum (August 7, 2012): Collaborative Umbrella CAPS Three Prevention Trial Initiatives

Publication Date: 
Tue, 08/07/2012

At this year's Alzheimer's Association International Conference, 14-19 July 12, in sunny Vancouver, Canada, some sessions unfolded, somewhat lonesomely, in large, sparsely populated lecture halls. This could not have been more different for a session titled "Collaboration for Alzheimer's Prevention:  Common Issues Across Presymptomatic Treatment Trials," People streamed into the room long after every seat was filled, and the crowd standing around them grew so large that fire safety rules forced closure of the room, resulting in dozens of conference attendees being turned away.

Syndicate content